Publication | Open Access

Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies

Ruxolitinib CreamAllergyAtopic DermatitisAllergy MedicinePediatricsSkin AllergyClinical DermatologyRandomized Phase 3DermatologySclerodermaMedicine